KSUCVM • COBRE

Center for Epithelial Function in Health and Disease

Investigator, Mentor(s) and Project

  Principal Investigators Project Mentors
Daniel C. Marcus, DSc

Daniel C. Marcus, DSc
University Distinguished Professor
Anatomy & Physiology, KSU

Program Director of this COBRE  
Peying Fong, PhD

Peying Fong, PhD
Assistant Professor
Anatomy & Physiology, KSU

Regulation of Epithelial Na+ Transport Function by CFTR Daniel C. Marcus, DSc University Distinguished Professor,
Anatomy & Physiology, KSU
Sherry Fleming, PhD

Sherry Fleming, PhD
Assistant Professor
Division of Biology, KSU

TLR Expression Alters Ischemia-induced Intestinal Epithelial Damage Stephen Keith Chapes, PhD Professor, Associate Director, Terry C. Johnson Cancer Center, KSU
James Lillich, DVM, MS

James Lillich, DVM, MS
Assoc. Prof.
Clinical Sciences, KSU

Intestinal Epithelial Wound Healing: NSAIDs and Calpain Inhibition Lisa Freeman, DVM, PhD Anatomy & Physiology, KSU
Dr. Tonatiuh Melgarejo Tonatiuh Melgarejo, PhD
Assist. Prof.
Human Nutrition, KSU

Characterization of Canine Urogenital Beta-Defensins, A Novel Family of Epithelium-derived Antimicrobial Peptides

Frank Blecha, PhD
Anatomy & Physiology, KSU
Thu Annelise Nguyen Thu Annelise Nguyen, PhD
Assist. Prof.
Diagnostic Medicine/Pathobiology, KSU
Anticancer Activities of Gap Junction Activators Jonathan Li, PhD
Professor,
Dept of Pharmacology, Toxicology and Therapeutics, KUMC,
 
Guido Zampighi, DDS, PhD,
Professor,
Dept of Molecular, Cellular and Integrative Physiology, UCLA
Yoonseong Park, PhD

Yoonseong Park, PhD
Assistant Professor
Entomology, KSU

Transepithelial Ion Transport in Mosquito Hindgut Controlled by Peptide Hormone Michael R. Kanost, PhD University Distinguished Professor and Department Head,
Department of Biochemistry, KSU
Min Pi, PhD

Min Pi, PhD
Research Assistant Professor
The Kidney Institute, KUMC

In Vivo Assessment of CASR Signaling Mechanisms L. Darryl Quarles MD Professor/Director,
The Kidney Institute, KUMC

Intestinal Epithelial Wound Healing: NSAIDs and Calpain Inhibition

Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely used medications worldwide despite their well-documented gastrointestinal (GI) toxicity. The GI epithelium has several functions, the most important of which are nutrient absorption and barrier function, separating the internal milieu from the external environment. Mucosal restitution represents a primary repair modality in the GI tract, and allows resealing of the epithelial barrier in minutes to hours via reformation of tight junctions between cells. Restitution requires cell migration, but not cell proliferation nor differentiation and it is a well coordinated event relying on numerous cellular pathways. Recent evidence suggests that calpains (cysteine proteases) are vital to several key pathways of cell migration. Recently we have shown that: a) irrespective of COX selectivity, ulcerogenic NSAIDs inhibit cell migration after wounding; b) individual NSAIDs differ significantly in their effects on the cellular signals that modulate cell migration; and c) ulcerogenic NSAIDs either down-regulate calpain gene expression or up-regulate the constituent inhibitor, calpastatin. The experiments proposed by this project are designed specifically to link NSAID inhibition of cell migration with NSAID effects on events vital to calpain function within differentiated intestinal epithelial cells (IECs). The specific aims of this project are to:

  1. Demonstrate that calpains are critical to normal IEC migration.

  2. Confirm that calpains are a target for NSAID-toxicity and disruption of intestinal epithelial wound healing.

  3. Determine the effects of NSAIDs on calpain-mediated adhesion dynamics.

The results of this project will provide valuable data immediately useful not only to the health care providers who need to make rational decisions about prescribing NSAIDs, but also to the industrial scientists who strive to develop less toxic alternatives to the drugs currently available. In addition, the knowledge gained from these studies may suggest novel strategies for the prevention and treatment of NSAID-induced GI ulcers, identify novel targets for new drug design, and initiate novel safety testing of new NSAIDs.

Characterization of Canine Urogenital Beta-Defensins, A Novel Family of Epithelium-derived Antimicrobial Peptides

Our project goals are to elucidate the mechanisms that regulate the synthesis and production of beta-defensins in urogenital epithelial cells. Better understanding of these epithelium–derived antibacterial peptides will demonstrate their potential biological role in fighting urinary tract infections (UTI) in dogs. Given the remarkable clinical and pathological similarities between affected humans and dogs with UTI, we expect that knowledge gained from this project will be used as a direct approach for utilizing the dog as a suitable animal model to study beta-defensins as a major component of the innate immunity in the host defense against urogenital pathogens.
 

Regulation of Epithelial Na+ Transport Function by CFTR.

The regulation of sodium absorption by epithelial cells is key to understanding the pathological disruptions in many human diseases, yet it remains poorly understood. Sodium absorption via the epithelial sodium channel, ENaC, is believed to be regulated by the Cystic Fibrosis Transmembrane Conductance Regulator, CFTR. CFTR is a multifunctional protein that not only functions as a cAMP-gated chloride channel, but that also exists in a macromolecular signaling complex, interacting directly with scaffolding proteins, upstream modulators and downstream effectors (egs. the beta-adrenergic receptor and SLC26 transporter family members). On the other hand, direct molecular interactions between CFTR and ENaC have not been demonstrated. In general, the regulation of ENaC's net contribution to epithelial transport may be accomplished by changing its gating, its single channel conductance and/or the number of functional channels in the plasma membrane. The thyroid gland is an organ in which CFTR-transporter interactions at the level of the macromolecular signaling complex may influence ENaC activity critically. The disruption of those interactions may dysregulate ENaC and cause disease. The present proposal asks whether CFTR regulates epithelial sodium absorption by influencing a constitutive property of all cells, endocytosis, and hence changing the numbers of ENaC in the membrane. With regard to mechanism,

  • Does activation of CFTR normally cause cells to release ATP into the apical compartment?

  • Does ATP stimulate endocytosis?

  • How does endocytosis modulate net epithelial sodium absorption?

To address this hypothesis, the proposed study will use primary porcine thyroid epithelial cultures, a robust, bidirectionally transporting epithelial preparation. The approach incorporates measurements of short-circuit current and employs specific pharmacologic tools in these measurements, as well as in fluorescence microscopic assays of endocytic uptake, cell surface biotinylation, and immunolocalization studies. The combination of several methodologies will enable clear answers to the posed questions to be drawn, leading to novel insights that in turn will clear a path toward future questions. It is envisaged that these studies will fill a gap in knowledge that presently impedes overall progress in understanding diseases as diverse as Pendred syndrome, cystic fibrosis and polycystic kidney disease.
 

Regulation of Gap Junction Activators

Breast cancer patients initially respond to estrogen ablation therapy, but estrogen-independent cells almost always aggressively emerge, and the disease eventually progresses to what is defined as estrogen-independent breast cancer; at which point the tumor is no longer responsive to estrogen ablation therapy, and unrestrained progression of the disease is inevitable. It is believed that restoring gap junction activity is linked to drug sensitivity and reduction of tumorigenicity. Thus, increasing gap junction activity in breast tumor cells provides the targets to enhance anti-neoplastic therapies. Our lab is interested in small molecules that specifically activate gap junction activity and inhibit cancer cell growth.
 

In Vivo Assessment of CASR Signaling Mechanisms

The calcium sensing receptor (CASR) plays a central role in controlling systemic calcium homeostasis via regulation of parathyroid hormone (PTH) production and controls a wide variety of processes in other tissues, including epithelia. We are using genetic engineering in mice to alter the expression of signaling molecules thought to be involved in cellular responses to CASR activation. Changes in several parameters, including PTH secretion and parathyroid cell growth, as a result of altering specific genes will be used to test hypotheses of the CASR signaling process.
 

Transepithelial Ion Transport in Mosquito Hindgut Controlled by Peptide Hormone

We are studying the mechanisms of transepithelial ion transport in the hindgut epithelial cells of the African malaria mosquito Anopheles Gambiae and its control by the peptide hormone “ion transport peptide.” Molecular biology of this endocrine peptide and hindgut epithelial physiology will be studied. Our research will provide rational approaches to develop environmentally benign insecticidal compounds that help to control diseases carried by these mosquitos.
 

TLR Expression Alters Ischemia-induced Intestinal Epithelial Damage

This project focuses on the mechanism of intestinal damage in response to ischemia/reperfusion (I/R) events including heart attacks and strokes. Intestinal damage due to I/R events is mediated by components of the immune system. One group of molecules called toll-like receptors are candidates for involvement. The goal of this project is to understand the extent that toll-like receptors contribute to intestinal damage. The hypothesis is that specific toll-like receptors cause the intestinal inflammation associated with damage induced by I/R. These studies will provide critical data to improve our understanding of I/R injury.
 


spacerK-State WebsiteKSUCVM MainpageAnatomy and Physiology  
spacer  

This section was last updated on:Thursday January 10 2008

© 1996-2008 Kansas State University College of Veterinary Medicine. Nondiscrimination Notice.

Kansas State University • College of Veterinary Medicine • 101 Trotter Hall • Manhattan KS 66506-5601